Skip to content

Pharminent

cropped-neurology_aaic_banner_frontpage_2026-07-15-1.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • M&A / Deals
  • A Spanish biotech banks $87M to make differentiated ADCs
  • M&A / Deals

A Spanish biotech banks $87M to make differentiated ADCs

BioPharma Dive

Ona Therapeutics, a Barcelona-based drugmaker, is developing next-generation drugs it says could help patients with advanced forms of breast and colorectal cancers.

Oncology

Read full story

pharminent June 4, 2026 (Last updated: June 4, 2026)

BioPharma Dive

Ona Therapeutics, a Barcelona-based drugmaker, is developing next-generation drugs it says could help patients with advanced forms of breast and colorectal cancers.

Oncology

Read full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: Legend surges on early data for ‘in vivo’ lymphoma cell therapy
Next: Cellares and TScan to assess automated manufacturing of TSC-101 therapy

Related Stories

  • M&A / Deals

Spero snaps up Innovent immunology drug in strategic pivot

pharminent July 14, 2026
  • M&A / Deals

AstraZeneca takes another China trip, picking Dizal’s lung cancer drug for up to $1.5B

pharminent July 14, 2026
  • M&A / Deals

Novartis and Chai Discovery collaborate on antibody identification

pharminent July 14, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.